Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Chin Chang

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
JACC. Cardiovascular Interventions|March 7, 2020
DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCIPly Chichareon, Rodrigo Modolo, Hideyuki Kawashima, et al.
The Canadian Journal of Cardiology|May 26, 2020
Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS TrialChao Gao, Piotr Buszman, Paweł Buszman, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2019
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trialKuniaki Takahashi, Ply Chichareon, Rodrigo Modolo, et al.
JACC. Cardiovascular Interventions|September 30, 2019
Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel DiseaseNorihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak, et al.
The Canadian Journal of Cardiology|March 7, 2020
Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERSAna Paula de Faria, Rodrigo Modolo, Ply Chichareon, et al.
European Heart Journal|August 10, 2019
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trialPatrick W Serruys, Kuniaki Takahashi, Ply Chichareon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2019
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trialPatrick W Serruys, Mariusz Tomaniak, Ply Chichareon, et al.
European Heart Journal|September 13, 2019
Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert reviewChun Chin Chang, Kevin M Veen, Rebecca T Hahn, et al.
Journal of the American College of Cardiology|October 19, 2019
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCIKuniaki Takahashi, Patrick W Serruys, Ply Chichareon, et al.
International Journal of Cardiology|March 9, 2019
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS studyPly Chichareon, Rodrigo Modolo, David van Klaveren, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
JACC. Cardiovascular Interventions|March 7, 2020
DAPT Score and the Impact of Ticagrelor Monotherapy During the Second Year After PCIPly Chichareon, Rodrigo Modolo, Hideyuki Kawashima, et al.
The Canadian Journal of Cardiology|May 26, 2020
Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS TrialChao Gao, Piotr Buszman, Paweł Buszman, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2019
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trialKuniaki Takahashi, Ply Chichareon, Rodrigo Modolo, et al.
JACC. Cardiovascular Interventions|September 30, 2019
Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel DiseaseNorihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak, et al.
The Canadian Journal of Cardiology|March 7, 2020
Association of Pulse Pressure With Clinical Outcomes in Patients Under Different Antiplatelet Strategies After Percutaneous Coronary Intervention: Analysis of GLOBAL LEADERSAna Paula de Faria, Rodrigo Modolo, Ply Chichareon, et al.
European Heart Journal|August 10, 2019
Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trialPatrick W Serruys, Kuniaki Takahashi, Ply Chichareon, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2019
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trialPatrick W Serruys, Mariusz Tomaniak, Ply Chichareon, et al.
European Heart Journal|September 13, 2019
Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert reviewChun Chin Chang, Kevin M Veen, Rebecca T Hahn, et al.
Journal of the American College of Cardiology|October 19, 2019
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCIKuniaki Takahashi, Patrick W Serruys, Ply Chichareon, et al.
International Journal of Cardiology|March 9, 2019
Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS studyPly Chichareon, Rodrigo Modolo, David van Klaveren, et al.
Pageof 10